CRMD - CorMedix Inc.
6.69
-0.030 -0.448%
Share volume: 1,395,366
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$6.72
-0.03
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 10-30-2024 | 03-25-2025 | 05-06-2025 | 08-07-2025 | 11-12-2025 | 03-05-2026 | |
| Total revenue | 0.000 | 1.306 M | 11.456 M | 30.710 M | 39.082 M | 39.737 M | 100.647 M | 118.372 M | |
| Cost of revenue | 818.539 K | 509.839 K | 686.598 K | 1.176 M | 1.597 M | 1.862 M | 7.566 M | 11.064 M | |
| Gross profit | -818.539 K | 296.280 K | 10.770 M | 30.034 M | 37.485 M | 37.874 M | 93.081 M | 107.308 M | |
| 136.20% | 3,534.91% | 178.88% | 24.81% | 1.04% | 145.76% | 15.28% | |||
| Operating expenses | 15.886 M | 8.210 M | 7.308 M | 2.498 M | 12.886 M | 11.947 M | 30.549 M | 32.172 M | |
| Selling general and admin | 15.048 M | 7.559 M | 6.581 M | 770.787 K | 9.693 M | 9.504 M | 25.451 M | 23.572 M | |
| Research and development | 837.445 K | 650.988 K | 727.119 K | 1.727 M | 3.192 M | 2.443 M | 5.098 M | 8.600 M | |
| Total expenses | 15.886 M | 15.597 M | 14.057 M | 17.098 M | 17.360 M | 18.331 M | 41.735 M | 48.182 M | |
| -1.82% | -9.88% | 21.64% | 1.53% | 5.59% | 127.67% | 15.45% | |||
| Operating income | -16.704 M | -15.301 M | -3.287 M | 12.936 M | 20.125 M | 19.544 M | 51.346 M | 59.126 M | |
| Ebit | -16.708 M | -15.302 M | -3.321 M | 13.464 M | 20.087 M | 19.527 M | 51.964 M | 57.374 M | |
| Pretax income | -15.861 M | -14.151 M | -2.777 M | 13.464 M | 20.644 M | 20.349 M | 52.576 M | 56.446 M | |
| -10.78% | -80.38% | -584.89% | 53.32% | -1.43% | 158.37% | 7.36% | |||
| Income tax | -1.395 M | 0.000 | 0.000 | 0.000 | 0.000 | 521.507 K | -55.987 M | 42.426 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -14.466 M | -14.151 M | -2.777 M | 13.464 M | 20.644 M | 19.828 M | 108.563 M | 14.020 M | |
| 2.17% | 80.38% | 584.89% | 53.32% | -3.95% | 447.52% | -87.09% |